Communication of the meeting of Transparency Council No. 34/2025 on 5 August 2025 with resolutions

At its meeting on 5 August 2025, the Transparency Council adopted position No. 105/2025 on the appraisal od drug Altuvoct (efanesoctocog alfa) under drug program B.15. “Prevention of bleeding in children with hemophilia A and B (ICD-10: D66, D67)”;
At its meeting on 5 August 2025, the Transparency Council adopted position No. 106/2025 on the appraisal of drug Phesgo (pertuzumab; trastuzumab) under the B.9.FM drug program. “Treatment of patients with breast cancer (ICD-10: C50)”;
At its meeting on 5 August 2025, the Transparency Council adopted position No. 107/2025 pn the appraisal of drug Blincyto (blinatumomab) under drug program B.65. “Treatment of patients with acute lymphoblastic leukemia (ICD-10: C91.0)”;
At its meeting on 5 August 2025, the Transparency Council adopted opinion No. 137/2025 on the draft program “Health policy program for first aid for students of public secondary schools in the Opole County for 2025-2028 ‘First Aid’”;
At its meeting on 5 August 2025, the Transparency Council adopted opinion No. 138/2025 about the draft program “Program for the prevention of depressive disorders among teenagers attending primary schools run by the City of Ząbki”;
At its meeting on 5 August 2025, the Transparency Council adopted opinion No. 139/2025 on the draft program “Health policy program for medical rehabilitation of residents of the Inowłódz municipality for the years 2026-2027.”